Saturday, April 20, 2024

No Result

View All Result

Media

No Result

View All Result

Health

We should change how we evaluate cancer drugs: Nigel Rawson, Chak Balijepalli and David Stewart in the Financial Post

April 16, 2024

Health

Commentary

Waiting for new drugs for rare disorders in Canada

September 6, 2023

Columns

Jordan Peterson’s regulator is fighting for itself, not patients: Shawn Whatley in the National Post

August 31, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada, part 8 – need for a national strategy: Nigel Rawson and John Adams for Inside Policy

August 30, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada, part 7 – Canadian Drug Agency: Nigel Rawson and John Adams for Inside Policy

August 23, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada, part 6 – national pharmacare: Nigel Rawson and John Adams for Inside Policy

August 16, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy

August 9, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy

August 2, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy

July 26, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

July 19, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

July 12, 2023

Time for the PMPRB to go: Nigel Rawson and Brett Skinner in the Hill Times

Columns

The PMPRB has outlived its usefulness: Nigel Rawson in the Hill Times

June 28, 2023

Canada’s blood plasma-collection model is broken

Papers

Paying for plasma: The case for commercial-compensated plasma collections

June 13, 2023

Page 3 of 29 Prev 1 2 3 4 … 29 Next

Newsletter Signup

Email Address *

First Name *

Last Name *

*Required Fields

Follow us on

Macdonald-Laurier Institute

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

No Result

View All Result

We should change how we evaluate cancer drugs: Nigel Rawson, Chak Balijepalli and David Stewart in the Financial Post

Health

Waiting for new drugs for rare disorders in Canada

Jordan Peterson’s regulator is fighting for itself, not patients: Shawn Whatley in the National Post

Waiting for new drugs for rare disorders in Canada, part 8 – need for a national strategy: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada, part 7 – Canadian Drug Agency: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada, part 6 – national pharmacare: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

The PMPRB has outlived its usefulness: Nigel Rawson in the Hill Times

Paying for plasma: The case for commercial-compensated plasma collections

Top News

In post-disaster rebuilding, government needs to get out of the way: Jerome Gessaroli in the Financial Post

Double Trouble – Facing the Sino-Russian axis: Balkan Devlen and Jonathan Berkshire Miller for Inside Policy Talks

Marcus Kolga on Russian information and influence campaigns in Canada: MLI in Parliament

Multimedia

Marcus Kolga on Russian information and influence campaigns in Canada: MLI in Parliament

Iranian attack ‘shifted the paradigm’: Aurel Braun on CTV News

Anti-money laundering watchdog gives failing grades to banks, real estate companies: Christian Leuprecht on Global News

Time for an intervention – an urgent call to end “gender-affirming” treatments for children: J. Edward Les for Inside Policy

Skiing down euthanasia’s slippery slope: John Keown for Inside Policy

The Lamentable Decline of Canada’s Reputation as a Dependable and Globally Respected Nation: Peter Menzies in the Epoch Times

Conservatives can reject destructive left-wing policies and still take climate change seriously: Brian Lee Crowley in the National Post

Success assured? Appraising the Canadian-led Enhanced Forward Presence battlegroup in Latvia

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

Support Us